Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Steinman

Showing results (1-10 of 226) with videos related to

Pageof 23
Sort By:
JAMA Internal Medicine|March 22, 2016
Polypharmacy-Time to Get Beyond NumbersMichael A Steinman
The American Journal of Geriatric Pharmacotherapy|January 9, 2008
Polypharmacy and the balance of medication benefits and risksMichael A Steinman
JAMA|April 3, 2002
The costs of making practice more cost-effectiveMichael A Steinman
Archives of Internal Medicine|September 14, 2011
Using patients to promote evidence-based prescribing: comment on "Communicating uncertainties about prescription drugs to the public"Michael A Steinman
JAMA Internal Medicine|February 6, 2013
Reaching out to patients to identify adverse drug reactions and nonadherence: necessary but not sufficientMichael A Steinman
Basic & Clinical Pharmacology & Toxicology|March 14, 2023
The future of deprescribing research: Seizing opportunities and learning from the pastMichael A Steinman
The New England Journal of Medicine|September 28, 2007
Number of medical conditions and quality of careMichael A Steinman
Journal of the American Geriatrics Society|July 23, 2025
Alternative Treatments to Selected Medications in the 2023 American Geriatrics Society Beers Criteria®, Michael A Steinman
BMJ Quality & Safety|November 26, 2018
Reducing hospital admissions for adverse drug events through coordinated pharmacist care: learning from Hawai'i without a field tripMichael A Steinman
Israel Journal of Health Policy Research|October 14, 2016
Perception of primary care physicians on the impact of comprehensive geriatric assessment: what is the next step?Pei Chen, Michael A Steinman
Pageof 23

Showing results (1-10 of 226) with videos related to

Sort By:
Pageof 23
JAMA Internal Medicine|March 22, 2016
Polypharmacy-Time to Get Beyond NumbersMichael A Steinman
The American Journal of Geriatric Pharmacotherapy|January 9, 2008
Polypharmacy and the balance of medication benefits and risksMichael A Steinman
JAMA|April 3, 2002
The costs of making practice more cost-effectiveMichael A Steinman
Archives of Internal Medicine|September 14, 2011
Using patients to promote evidence-based prescribing: comment on "Communicating uncertainties about prescription drugs to the public"Michael A Steinman
JAMA Internal Medicine|February 6, 2013
Reaching out to patients to identify adverse drug reactions and nonadherence: necessary but not sufficientMichael A Steinman
Basic & Clinical Pharmacology & Toxicology|March 14, 2023
The future of deprescribing research: Seizing opportunities and learning from the pastMichael A Steinman
The New England Journal of Medicine|September 28, 2007
Number of medical conditions and quality of careMichael A Steinman
Journal of the American Geriatrics Society|July 23, 2025
Alternative Treatments to Selected Medications in the 2023 American Geriatrics Society Beers Criteria®, Michael A Steinman
BMJ Quality & Safety|November 26, 2018
Reducing hospital admissions for adverse drug events through coordinated pharmacist care: learning from Hawai'i without a field tripMichael A Steinman
Israel Journal of Health Policy Research|October 14, 2016
Perception of primary care physicians on the impact of comprehensive geriatric assessment: what is the next step?Pei Chen, Michael A Steinman
Pageof 23